Clinical Trials Browser

Recruiting × Pituitary ACTH Hypersecretion × Endocrine × Clear all

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT00001595 2026-06-01

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Combined Pituitary Hormone Deficiency, Congenital Abnormalities, Acromegaly, Gigantism, Prolactinoma, Pituitary ACTH Hypersecretion, Carcinogenesis

NCT07460232 2026-05-29

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Phase EARLY_PHASE1 Recruiting

50 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT04569591 2026-04-09

DDAVP for Pituitary Adenoma

Phase NA Recruiting

22 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07463625 2026-03-11

PiTFET

Recruiting

20 enrolled

Endocrine

Pituitary Diseases, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT07335315 2026-01-13

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Recruiting

110 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT03364803 2025-10-23

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Recruiting

300 enrolled

Endocrine

Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT05971758 2025-07-04

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

Phase 2 Recruiting

20 enrolled

Endocrine

Pituitary ACTH Hypersecretion

Clinical Trials

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

DDAVP for Pituitary Adenoma

PiTFET

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease